COVID-19 News Updates LIVE: Covovax to get approval as booster in 10-15 days, says SII

[ad_1]

Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works very well against the Omicron variant of coronavirus.

Speaking to reporters on the sidelines of an event at Bharti Vidyapeeth University here, Poonawalla, when asked about states and districts not getting Covishield vaccines, said there are ample stocks with the Union government for supply.

“Covovax will be approved as a booster in the next 10-15 days. It is actually the best booster because it works very well against Omicron, more than Covishield,” said Poonawalla.

!1 New UpdateClick here for latest updates

Candian COVID-19 expert under scrutiny

Chinese doctors asked to avoid listing COVID-19 as cause of death

China has kept its COVID-19 death toll at a little over 5000, despite funeral homes across the country reportedly overflowing amid an increase in virus cases. Chinese doctors have been asked to avoid listing COVID-19 as a cause of death, NTD reported.

A doctor at a hospital in Beijing was asked to not report COVID-19 as the primary cause of death, NTD reported citing The New York Times. Similar warnings have been circulated on Chinese social media. A group chat conversation has asked doctors to not list the COVID-19 virus as the cause of death, as per the NTD report.

In China, only those who die after respiratory failure caused by COVID-19 count as COVID-19 death. COVID-19 patients who die with pre-medical conditions do not count as COVID-19 death even if the virus worsened their health condition, as per the news report.

SK Bioscience chief says “national pride” prevents China from accepting foreign COVID vaccines

SK Bioscience Co Ltd chief executive Jaeyong Ahn said in a Financial Times interview that it is unlikely that the vaccine maker can supply COVID-19 vaccines to China amid its recent outbreak due to Beijing’s “national pride”.

Ahn said that it was “unrealistic” to supply COVID vaccines to China, as the country insists on using its domestic vaccines, the newspaper quoted him as saying.

Chinese doctors asked to avoid listing COVID-19 as cause of death

China has kept its COVID-19 death toll at a little over 5000, despite funeral homes across the country reportedly overflowing amid an increase in virus cases. Chinese doctors have been asked to avoid listing COVID-19 as a cause of death, NTD reported.

A doctor at a hospital in Beijing was asked to not report COVID-19 as the primary cause of death, NTD reported citing The New York Times. Similar warnings have been circulated on Chinese social media. A group chat conversation has asked doctors to not list the COVID-19 virus as the cause of death, as per the NTD report.

China lifts pandemic border controls

On Sunday, China fully opened its borders for the first time since the coronavirus pandemic began, welcoming visitors without strict quarantine requirements and allowing its citizens to go overseas once again just as the travel period for Lunar New Year, typically the busiest season, begins. In Hong Kong’s airport, hundreds of people waited to check in for flights to cities in the south like Xiamen and Chongqing and in the north like Beijing and Tianjin, but the arrivals hall was more quiet. Many of the city’s border checkpoints were reopened; empty transportation halls filled up with groups of people, and shuttered storefronts were open once again.

Foreign visitors in Israel surge in 2022 amid post-Covid tourism recovery

The number of foreign tourists visiting Israel in 2022 reached 2.7 million, according to an annual report issued by the country’s Central Bureau of Statistics.

The figure represents a 6.8-fold increase, compared to 396,500 foreign tourists who visited Israel in 2021, when the country imposed entry restrictions because of the Covid-19 pandemic.

Vaccinated and recovered tourists were allowed to enter Israel in January 2022. Two months later, Israel opened its borders to all tourists.

Covovax to get approval as booster in 10-15 days

Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works very well against the Omicron variant of coronavirus.

Speaking to reporters on the sidelines of an event at Bharti Vidyapeeth University here, Poonawalla, when asked about states and districts not getting Covishield vaccines, said there are ample stocks with the Union government for supply.



[ad_2]

Source link


Leave a Reply

Your email address will not be published. Required fields are marked *